Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept - Hirota, T; Suzuki, T; Ogishima, H (Modern Rheumatology/the Japan Rheumatism Association, 2016)
et al.